This inventor holds 1 USPTO granted patent. Top assignee: Abl Bio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kyung Jin Park: Innovator in Bispecific Antibodies
Introduction
Kyung Jin Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Kyung Jin Park holds a patent for "ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF." This innovative patent highlights his expertise in creating targeted therapies that can potentially improve treatment outcomes for patients.
Career Highlights
Currently, Kyung Jin Park is associated with Abl Bio Inc., a company focused on developing innovative biopharmaceuticals. His role at Abl Bio Inc. allows him to leverage his skills and knowledge in the field of antibody engineering.
Collaborations
He collaborates with talented individuals such as Yang Soon Lee and Sae Yi Lim, who contribute to the research and development efforts at Abl Bio Inc. Their teamwork enhances the potential for groundbreaking discoveries in the field.
Conclusion
Kyung Jin Park's contributions to bispecific antibodies exemplify the innovative spirit in biomedicine. His work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile